$30.26-5.56%
2026-10-08 closeLoading chart…
Immunovant's chart data is dated 2026-10-08. There is no active technical signal. There are 8 published signal records.
Immunovant last closed at $30.26 (-5.56%) on 2026-10-08. Listed on Nasdaq. Trailing 12 months PER is -11.6×. Its overall grade ranks 254 of 738 stocks in Healthcare.
About this company
Immunovant last closed at $30.26 (-5.56%) on 2026-10-08. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall B+ · 254/738
Valuation grade B
Related stocks
- ArgenxCompetitor
FcRn 계열 자가면역질환 치료제 개발 경쟁사
- UCBCompetitor
중증 자가면역·신경계 질환 치료제 시장에서 경쟁
- Johnson & JohnsonCompetitor
자가면역·면역질환 치료제 포트폴리오를 보유한 대형 경쟁사
About Immunovant
- What technical signals does Immunovant (IMVT) have?
- Immunovant current technical signals: no active technical signal.
- Is Immunovant a cup-and-handle pattern?
- No. Immunovant has no valid Cup signal right now.
- What published figures are available for Immunovant?
- Market cap: $6.13B. Trailing 12 months PER: -11.6×. Latest quarter PBR: 8.46×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Immunovant, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy